Works by Tzeng, Huey-En


Results: 28
    1
    2
    3

    High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan.

    Published in:
    Cancers, 2021, v. 13, n. 7, p. 1620, doi. 10.3390/cancers13071620
    By:
    • Tsai, Cheng-Chih;
    • Su, Yung-Cheng;
    • Bamodu, Oluwaseun Adebayo;
    • Chen, Bo-Jung;
    • Tsai, Wen-Chiuan;
    • Cheng, Wei-Hong;
    • Lee, Chii-Hong;
    • Hsieh, Shu-Min;
    • Liu, Mei-Ling;
    • Fang, Chia-Lang;
    • Lin, Huan-Tze;
    • Chen, Chi-Long;
    • Yeh, Chi-Tai;
    • Lee, Wei-Hwa;
    • Ho, Ching-Liang;
    • Lai, Shiue-Wei;
    • Tzeng, Huey-En;
    • Hsieh, Yao-Yu;
    • Chang, Chia-Lun;
    • Zheng, Yu-Mei
    Publication type:
    Article
    4
    5
    6

    Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients.

    Published in:
    Biomarker Research, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40364-024-00715-5
    By:
    • Cheng, Tzu-Chun;
    • Hung, Mien-Chie;
    • Wang, Lu-Hai;
    • Tu, Shih-Hsin;
    • Wu, Chih-Hsiung;
    • Yen, Yun;
    • Chen, Chi-Long;
    • Whang-Peng, Jacqueline;
    • Lee, Wen-Jui;
    • Liao, You-Cheng;
    • Lee, Yu-Ching;
    • Pan, Min-Hsiung;
    • Lin, Hui-Kuan;
    • Tzeng, Huey-En;
    • Guo, Peixuan;
    • Chu, Cheng-Ying;
    • Chen, Li-Ching;
    • Ho, Yuan-Soon
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    In Vitro Study on AI‐PRS Enabled Precision Cocktail Drugs Design for Treating Human Colorectal Carcinoma.

    Published in:
    Advanced Therapeutics, 2023, v. 6, n. 6, p. 1, doi. 10.1002/adtp.202200298
    By:
    • Yang, Hsin‐Yu;
    • Goudar, Venkanagouda S.;
    • Hung, Yi‐Chi;
    • Ouyang, Chih‐Hsuan;
    • Rashid, Masturah Bte Mohd Abdul;
    • Juo, Liang‐Yi;
    • Wu, Jen‐Kuei;
    • Cheng, Ya‐Wen;
    • Wei, Po‐Li;
    • Tzeng, Huey‐En;
    • Jiang, Jeng‐Kai;
    • Chow, Edward Kai‐Hua;
    • Yang, Chih‐Yung;
    • Ho, Chih‐Ming;
    • Yen, Yun;
    • Tseng, Fan‐Gang
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression.

    Published in:
    Diagnostics (2075-4418), 2023, v. 13, n. 9, p. 1597, doi. 10.3390/diagnostics13091597
    By:
    • Ho, Chin-Beng;
    • Tsai, Jo-Ting;
    • Chen, Chun-You;
    • Shiah, Her-Shyong;
    • Chen, Hsuan-Yu;
    • Ting, Lai-Lei;
    • Kuo, Chia-Chun;
    • Lai, I-Chun;
    • Lai, Hsin-Yi;
    • Chung, Chi-Li;
    • Lee, Kai-Ling;
    • Tzeng, Huey-En;
    • Lee, Kuen-Haur;
    • Lee, Hsin-Lun;
    • Chen, Shang-Wen;
    • Chiou, Jeng-Fong
    Publication type:
    Article
    28

    The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.671127
    By:
    • Hsu, Jason C.;
    • Nguyen, Phung-Anh;
    • Chen, Yen-Tzu;
    • Yang, Szu-Chun;
    • Lin, Chien-Chung;
    • Yang, Yi-Hsin;
    • Lin, Yu-Chao;
    • Hsia, Te-Chun;
    • Hsieh, Hsing-Chun;
    • Wu, Jia-Syuan;
    • Chang, Chi-Pei;
    • Feng, Yin-Hsun;
    • Lin, Peng-Chan;
    • Hsu, Ping-Chih;
    • Tzeng, Huey-En;
    • Chien, Shu-Chen;
    • Chang, Wei-Chiao;
    • Chang, Chih-Cheng;
    • Yang, Hsuan-Chia;
    • Lee, Chueh Ming
    Publication type:
    Article